Ionian Technologies Gets Gates Funding for MDx Platform | GenomeWeb

NEW YORK (GenomeWeb News) – Ionian Technologies today said that it has received additional funding from the Bill & Melinda Gates Foundation to continue developing a molecular diagnostics platform designed for use in the developing world.

The San Diego-based firm said that its total commitment from the Gates foundation has risen to $3 million over two years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.